Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Protalix BioTherapeutics, Inc. (PLX) had Pre-Tax Income of $4.86M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$19.90M |
|
$3.78M |
|
$7.76M |
|
$12.13M |
|
$15.22M |
|
$4.67M |
|
$0.19M |
|
|
Pre-Tax Income |
$4.86M |
$4.86M |
|
$3.78M |
|
$3.78M |
|
$3.78M |
|
$3.78M |
|
$4.67M |
|
$5.08M |
|
79.99M |
|
82.56M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$92.22M |
|
$5.47M |
|
$18.12M |
|
$110.34M |
|
$31.39M |
|
-- |
|
$7.54M |
|
$38.93M |
|
$71.40M |
|
$71.40M |
|
$71.40M |
|
80.57M |
|
| Cash Flow Statement Financials | |
$11.62M |
|
$0.59M |
|
$0.15M |
|
$14.68M |
|
$27.42M |
|
$12.74M |
|
$0.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
60.99% |
|
23.48% |
|
23.48% |
|
-- |
|
24.43% |
|
18.98% |
|
$10.27M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.24 |
|
1.21 |
|
74.65 |
|
5.29% |
|
5.29% |
|
3.42% |
|
5.29% |
|
$0.89 |
|
$0.12 |
|
$0.14 |
|